Blanca A-G
@blanka-g.bsky.social
Excited to share that our research is now published!
Huge congrats to Ana C. Almansa García, and many thanks to Marius Ueffing, Angela Armento, and all co-authors!
🔗 link.springer.com/article/10.1...
@eye-tuebingen.bsky.social
#Proteostasis #VCP #RetinalDegeneration #PreclinicalResearch
Huge congrats to Ana C. Almansa García, and many thanks to Marius Ueffing, Angela Armento, and all co-authors!
🔗 link.springer.com/article/10.1...
@eye-tuebingen.bsky.social
#Proteostasis #VCP #RetinalDegeneration #PreclinicalResearch
Safety and neuroprotective efficacy of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo study - BMC Medicine
Background Retinal degenerative diseases represent a complex global health problem due to their significant impact on patients’ daily lives and their highly heterogeneous pathogenesis, which challenge...
link.springer.com
January 16, 2026 at 1:12 PM
Excited to share that our research is now published!
Huge congrats to Ana C. Almansa García, and many thanks to Marius Ueffing, Angela Armento, and all co-authors!
🔗 link.springer.com/article/10.1...
@eye-tuebingen.bsky.social
#Proteostasis #VCP #RetinalDegeneration #PreclinicalResearch
Huge congrats to Ana C. Almansa García, and many thanks to Marius Ueffing, Angela Armento, and all co-authors!
🔗 link.springer.com/article/10.1...
@eye-tuebingen.bsky.social
#Proteostasis #VCP #RetinalDegeneration #PreclinicalResearch